Lung Cancer Clinical Trials

Find Lung Cancer Clinical Trials Near You

Study on the Diagnosis of Ground-glass Lung Cancer by Microwave Ablation Combined With Puncture Biopsy

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study is a multicenter study. It plans to screen 200 patients with pulmonary nodule lesions with ground glass as the main body, take CT thin-layer scanning 3D reconstruction, apply AI and fragment omics technology to evaluate the risk of malignant transformation of pulmonary nodules, and use microwave ablation to treat pulmonary nodules and combine intraoperative rapid pathology technology to determine the nature of puncture tissue and the degree of ablation, and then explore the optimal ablation time and ablation power.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Age ≤ 75 years;

• GGN patients with the maximum axial diameter of the lesion in the lung window ≤ 3 cm;

• Refusing radical surgery or being unable to tolerate surgical treatment;

• Normal coagulation function, platelet count ≥ 60 × 109 /L;

• ECOG score ≤ 2 points;

Locations
Other Locations
China
Beidahuang Industry Group General Hospital
RECRUITING
Harbin
Contact Information
Primary
Mingyang Liu
redrumff@163.com
86+451 5519 7877
Time Frame
Start Date: 2025-01-15
Estimated Completion Date: 2028-01-15
Participants
Target number of participants: 200
Treatments
Experimental: Microwave ablation combined with biopsy
Microwave ablation combined with biopsy
Related Therapeutic Areas
Sponsors
Leads: Beidahuang Industry Group General Hospital

This content was sourced from clinicaltrials.gov